Werner Fabry

804 total citations
24 papers, 624 citations indexed

About

Werner Fabry is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Werner Fabry has authored 24 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Werner Fabry's work include Mycobacterium research and diagnosis (5 papers), Antimicrobial agents and applications (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Werner Fabry is often cited by papers focused on Mycobacterium research and diagnosis (5 papers), Antimicrobial agents and applications (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Werner Fabry collaborates with scholars based in Germany, Kenya and Austria. Werner Fabry's co-authors include R. Ansorg, P. O. Okemo, H.-J. Kock, W. Vahlensieck, Ernst N. Schmid, K. P. Schmit-Neuerburg, W. Schlickewei, H. Hirche, K. Renzing‐Köhler and Peter‐Michael Rath and has published in prestigious journals such as Journal of Ethnopharmacology, Journal of Medical Microbiology and Journal of Hospital Infection.

In The Last Decade

Werner Fabry

23 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Werner Fabry Germany 10 247 191 121 103 92 24 624
Silvia Bittner Fialová Slovakia 15 216 0.9× 267 1.4× 281 2.3× 85 0.8× 84 0.9× 42 852
Ma B China 16 233 0.9× 166 0.9× 192 1.6× 64 0.6× 98 1.1× 46 658
Shalini Goel India 11 145 0.6× 106 0.6× 90 0.7× 91 0.9× 57 0.6× 34 583
Fatma Alzahraa Mokhtar Egypt 15 142 0.6× 103 0.5× 172 1.4× 70 0.7× 66 0.7× 61 601
P.J. Houghton United Kingdom 17 384 1.6× 268 1.4× 277 2.3× 74 0.7× 68 0.7× 30 814
Dae-Ki Joung South Korea 13 119 0.5× 181 0.9× 269 2.2× 29 0.3× 90 1.0× 16 733
Assia Hamdi Tunisia 15 178 0.7× 194 1.0× 134 1.1× 41 0.4× 60 0.7× 47 565
Jonatas Rafael de Oliveira Brazil 15 203 0.8× 269 1.4× 151 1.2× 76 0.7× 89 1.0× 33 660
Tamer Essawi Palestinian Territory 11 353 1.4× 377 2.0× 256 2.1× 312 3.0× 116 1.3× 21 1.0k
Tatiana Fernanda Bachiega Brazil 15 152 0.6× 253 1.3× 118 1.0× 74 0.7× 60 0.7× 20 705

Countries citing papers authored by Werner Fabry

Since Specialization
Citations

This map shows the geographic impact of Werner Fabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Fabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Fabry more than expected).

Fields of papers citing papers by Werner Fabry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Fabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Fabry. The network helps show where Werner Fabry may publish in the future.

Co-authorship network of co-authors of Werner Fabry

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Fabry. A scholar is included among the top collaborators of Werner Fabry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Fabry. Werner Fabry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rudolph, R., et al.. (2017). Management multiresistenter Erreger in der Urologie. Der Urologe. 56(6). 764–772. 2 indexed citations
2.
Vahlensieck, W., et al.. (2015). Long-Term Results after Acute Therapy of Obstructive Pyelonephritis. Urologia Internationalis. 94(4). 436–441. 9 indexed citations
3.
Fabry, Werner, et al.. (2013). Activity of the antiseptic polyhexanide against meticillin-susceptible and meticillin-resistant Staphylococcus aureus. Journal of Global Antimicrobial Resistance. 1(4). 195–199. 9 indexed citations
4.
Fabry, Werner & H.-J. Kock. (2013). In-vitro activity of polyhexanide alone and in combination with antibiotics against Staphylococcus aureus. Journal of Hospital Infection. 86(1). 68–72. 20 indexed citations
5.
Fabry, Werner, et al.. (2013). In-vitro analysis of the effect of gentamicin and polyhexanide on bone tissue. International Orthopaedics. 37(4). 761–767. 2 indexed citations
6.
Fabry, Werner, et al.. (2013). Activity of the Antiseptic Polyhexanide Against Gram-Negative Bacteria. Microbial Drug Resistance. 20(2). 138–143. 23 indexed citations
7.
Birgelen, C. von, J. v. Schönfeld, Günter Görge, Werner Fabry, & Peter Layer. (2008). Amöbenabszeß der Leber mit hepatobronchialer Fistel. DMW - Deutsche Medizinische Wochenschrift. 119(30). 1034–1038.
8.
Fabry, Werner, et al.. (2006). Bacterial decontamination of surgical wounds treated with Lavasept®. International Journal of Hygiene and Environmental Health. 209(6). 567–573. 19 indexed citations
9.
Fabry, Werner, et al.. (2003). Isolation and purification of chlamydospores ofCandida albicans. Medical Mycology. 41(1). 53–58. 8 indexed citations
10.
Ansorg, R., et al.. (2002). Influence of Mucin on the Activity of the Antiseptic Lavasept<sup>®</sup> against <i>Staphylococcus aureus</i>. Chemotherapy. 48(3). 129–133. 12 indexed citations
11.
Schmit-Neuerburg, K. P., W. Schlickewei, Werner Fabry, et al.. (2001). Wirksamkeit eines neuartigen Antisepticum in der Behandlung kontaminierter Weichteilwunden. Der Chirurg. 72(1). 61–71. 30 indexed citations
12.
Fabry, Werner, P. O. Okemo, & R. Ansorg. (1998). Antibacterial activity of East African medicinal plants. Journal of Ethnopharmacology. 60(1). 79–84. 317 indexed citations
13.
Fabry, Werner, E. N. Schmid, & R. Ansorg. (1996). Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium avium complex. Journal of Medical Microbiology. 44(3). 227–230. 10 indexed citations
14.
Fabry, Werner, P. O. Okemo, & R. Ansorg. (1996). Activity of East African Medicinal Plants against <i>Helicobacter pylori</i>. Chemotherapy. 42(5). 315–317. 34 indexed citations
15.
Fabry, Werner, et al.. (1996). Fungistatic and fungicidal activity of East African medicinal plants. Mycoses. 39(1-2). 67–70. 75 indexed citations
16.
Fabry, Werner, Ernst N. Schmid, & R. Ansorg. (1995). Comparison of the E Test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis. Zentralblatt für Bakteriologie. 282(4). 394–401. 2 indexed citations
17.
Fabry, Werner, Ernst N. Schmid, & R. Ansorg. (1995). Comparison of the E Test and a Proportion Dilution Method for Susceptibility Testing of <i>Mycobacterium kansasii</i>. Chemotherapy. 41(4). 247–252. 9 indexed citations
18.
Budach, Volker, M. Bamberg, C. Streffer, et al.. (1989). Establishment and characterization of human tumours in nu/nu-mice.. PubMed. 165(7). 500–1. 7 indexed citations
19.
Bojar, Hans & Werner Fabry. (1985). Dexamethasone, medroxyprogesterone acetate, and vindesine modulation of human malignant melanoma growth in soft agar.. PubMed. 5(2). 189–92. 2 indexed citations
20.
Bojar, Hans, et al.. (1983). 554 Effects of medroxyprogesterone acetate (mpa) on the growth of human bronchial carcinomas as well as malignant melanoma in soft agar culture. Journal of Steroid Biochemistry. 19. 196–196. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026